{"domain":"nutriband.com","status":"valid","tier":"listed","authority":45,"verified":false,"title":"Nutriband","summary":"Nutriband Inc. is a pharmaceutical company focused on developing transdermal drug delivery systems, particularly its AVERSA™ abuse-deterrent technology designed to prevent misuse of medications. The site offers extensive investor relations resources, including financial statements, SEC filings, and stock information, alongside details about its product pipeline and subsidiaries. Nutriband's mission centers on addressing the opioid crisis through innovative pharmaceutical solutions and improving ","country":"US","country_source":"ip","publisher_country":null,"publisher_country_source":null,"hosting_country":"US","llms_txt":"https://nutriband.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-25T23:17:24.630Z","agent_terms":null,"categories":["healthcare"],"capabilities":["mcp"],"inferred_tags":["transdermal drug delivery","abuse-deterrent technology","aversa","pharmaceutical pipeline","investor relations"],"audience":"business","agent_uses":["read_docs","search_content"],"language":"en","platform_generated":true,"agent_summary":"Nutriband Inc. pharmaceutical company developing transdermal drug delivery with AVERSA abuse-deterrent technology; site offers SEC filings and investor data.","llms_txt_cached":"https://agentwebmap.com/v1/domain/nutriband.com/llms.txt","agentic":"interface","section_keys":["ai-agent-access","available-mcp-tools","callwixsiteapi","generatevisitortoken","getbusinessdetails","homepage-link","notes","readfulldocsarticle","readfulldocsmethodschema","searchinsite","searchsiteapidocs","what-visitors-can-do-via-ai-plus-mcp"],"section_partial":false,"section_indexed_at":"2026-10-25T23:17:35.152Z"}